Overcoming Methodological Challenges for Advancing Stem Cell Therapies in Parkinson's Disease
Stephen Polgar1, David I Finkelstein2, Leila Karimi1,3
1School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.
Cell Transplantation
|April 18, 2024
Summary
Stem cell therapy shows promise for Parkinson's disease (PD) treatment, offering a proof-of-principle for brain repair. Addressing methodological challenges is crucial for advancing these innovative PD therapies.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Cell Therapy
Background:
- Parkinson's disease (PD) lacks curative treatments, driving research into novel therapeutic strategies.
- Stem cell research presents a potential avenue for PD treatment, though its efficacy and safety are debated.
- Previous clinical trials using dopaminergic fetal stem cells have faced challenges.
Purpose of the Study:
- To review studies on dopaminergic fetal stem cells for PD treatment.
- To analyze the design and results of initial surgical placebo-controlled trials.
- To identify and propose solutions for methodological challenges in stem cell therapy for PD.
Main Methods:
- Systematic review of existing literature on stem cell trials for PD.
- Analysis of clinical trial designs, including placebo-controlled studies.
- Identification of fundamental methodological challenges and potential strategies for resolution.
Main Results:
- Clinical trials demonstrate a proof-of-principle for cell replacement strategies in brain reconstruction.
- Methodological challenges in cell therapies for PD require careful consideration.
- Conflicting viewpoints highlight misunderstandings that impede progress.
Conclusions:
- Stem cell therapies hold potential for Parkinson's disease treatment, contingent on overcoming technical and methodological hurdles.
- Further research and innovation are essential to unlock the full potential of stem cell-based therapies for PD.
- Addressing key challenges is vital for the advancement of stem cell therapies in PD treatment.
Related Concept Videos
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
Stem Cell Culture
5.2K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.2K


